NSEAcquisition18 Jun 2026 · 18 Jun 2026, 12:20 pm
Acquisition
Aster DM Healthcare Limited · ASTERDM
✦ AI SummaryM&A
Aster DM Healthcare Limited has acquired 4,50,89,995 equity shares in its wholly owned subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, through a rights issue.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aster DM Healthcare Limited has informed the Exchange about Acquisition
Attachments (1)
📄pdf
Download →
ASTERDM2_18062026121918_STXSarjapurRightssigned.pdf
View document text
June 18, 2026
To To
The Secretary, The Manager,
Listing Department, Listing Department,
BSE Limited, The National Stock Exchange of India Ltd,
1st Floor, Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex,
Dalal Street, Mumbai 400001. Bandra (East), Mumbai 400051.
Scrip Code: 540975 Scrip Symbol: ASTERDM
Dear Sir/ Madam,
Sub: Intimation of acquisition of 4,50,89,995 equity shares in Aster DM Super-Specialty Hospital
(Sarjapur) Private Limited (“Sarjapur Entity”), a subsidiary of Aster DM Healthcare Limited (“Company”)
Ref: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (“SEBI Listing Regulations”)
Pursuant to Regulation 30 of the SEBI Listing Regulations, this is to inform you that the Company today,
i.e. June 18, 2026, has acquired 4,50,89,995 equity shares of Rs. 10/- each through rights issue in the
Sarjapur Entity.
The details as required under Regulation 30 of the SEBI Listing Regulations read with SEBI Master Circular
No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are given in “Annexure I”.
The above-mentioned information will also be available on the website of the Company at
https://www.asterdmhealthcare.in.
We request you to kindly take the above information on record.
Thanking you,
For Aster DM Healthcare Limited
Hemish Purushottam
Company Secretary and Compliance Officer
M. No. A24331
Annexure I
Details as required under Regulation 30 of the SEBI Listing Regulations read along with SEBI Master
Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
Sr. Particulars Details
1 Name of the target entity, details in brief Name: Aster DM Super-Specialty Hospital (Sarjapur)
such as size, turnover etc. Private Limited (“Sarjapur Entity”)
Date of incorporation: July 21, 2025
Authorized Share Capital: Rs. 153,55,00,000/-
(Rupee One Hundred and Fifty-Three Crore and Fifty-
Five Lakhs Only) comprising 10,00,00,000 equity
shares of Rs.10/- each, 38,40,000 Series A
compulsorily convertible preference shares of Rs.
50/- each and 68,70,000 Series B compulsorily
convertible preference shares of Rs. 50/- each.
Paid-up Share Capital: Rs. 50,10,00,000/- (Rupee
Fifty Crore and Ten Lakhs Only) comprising
5,01,00,000 equity shares of Rs. 10/- each
Size/Turnover: Not applicable, since the entity is yet
to commence its business.
2 Whether the acquisition would fall within Sarjapur Entity, being a wholly owned subsidiary of
related party transaction(s) and whether the Company, is a related party of the Company. The
the promoter/ promoter group/ group transaction falls within the ambit of related party
companies have any interest in the entity transactions. However, the transaction is between a
being acquired? If yes, nature of interest holding company and wholly owned subsidiary, and
and details thereof and whether the same as such exempted from the provisions in respect of
is done at “arm’s length” related party transactions as per Regulation 23(5) of
SEBI Listing Regulations.
Apart from the aforesaid, the promoter / promoter
group/ group companies do not have any interest in
Sarjapur Entity.
The transaction is done at an arm’s length basis.
Sr. Particulars Details
3 Industry to which the entity being Healthcare services
acquired belongs
4 Objects and impact of acquisition The investment by the Company is being made for
(including but not limited to, disclosure of general corporate purposes of the Sarjapur entity.
reasons for acquisition of target entity, if
its business is outside the main line of
business of the listed entity)
5 Brief details of any governmental or Not Applicable
regulatory approvals required for the
acquisition;
6 Indicative time period for completion of Sarjapur Entity has allotted 4,50,89,995 equity
the acquisition; shares of Rs. 10/- each on June 18, 2026.
7 Consideration - whether cash Cash consideration
consideration or share swap or any other
form and details of the same;
8 Cost of acquisition and/or the price at Rs. 45,08,99,950/- comprising of 4,50,89,995 equity
which the shares are acquired; shares of Rs. 10/- each
9 Percentage of shareholding / control 100% shareholding of the Sarjapur Entity is held by
acquired and / or number of shares the Company.
acquired;
4,50,89,995 equity shares of Rs. 10/- each have been
acquired.
10 Brief background about the entity Sarjapur Entity has been incorporated on July 21,
acquired in terms of products/line of 2025, in Bengaluru, Karnataka, India, inter alia, to
business acquired, date of incorporation, carry on the business of setting up and operating
history of last 3 years turnover, country in healthcare services.
which the acquired entity has presence
and any other significant information (in Turnover: Not applicable, since the entity is yet to
brief); commence its business.